Grant Yonehiro - 31 Dec 2022 Form 5 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role
Chief Business Officer
Signature
/s/ William P. Quinn, Attorney-in-Fact
Issuer symbol
BOLT
Transactions as of
31 Dec 2022
Net transactions value
+$7,055
Form type
5
Filing time
07 Feb 2023, 15:54:53 UTC
Previous filing
23 Feb 2022
Next filing
28 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BOLT Common Stock Purchase $4,101 +2,500 +176% $1.64 3,918 06 Jun 2022 Direct F1
transaction BOLT Common Stock Purchase $2,954 +2,500 +64% $1.18 6,418 06 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired under the issuer's Employee Stock Purchase Plan.